These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 15768566)

  • 41. [Liposome-encapsulated hemoglobin ameliorates brain dysfunction after transient cerebral ischemia in rats].
    Yamaguchi T; Hamadate N; Sugawara A; Togashi H; Yamamoto T; Yoshioka M
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2012 Apr; 32(2):97-9. PubMed ID: 22708265
    [No Abstract]   [Full Text] [Related]  

  • 42. Hemoglobin-based oxygen carriers.
    Stowell CP
    Curr Opin Hematol; 2002 Nov; 9(6):537-43. PubMed ID: 12394179
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Complement activation in vitro by the red cell substitute, liposome-encapsulated hemoglobin: mechanism of activation and inhibition by soluble complement receptor type 1.
    Szebeni J; Wassef NM; Hartman KR; Rudolph AS; Alving CR
    Transfusion; 1997 Feb; 37(2):150-9. PubMed ID: 9051089
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Characteristics of Hb-vesicles and encapsulation procedure.
    Takeoka S; Sakai H; Terase K; Nishide H; Tsuchida E
    Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(3):861-6. PubMed ID: 7994410
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Modified hemoglobin-based blood substitutes: crosslinked, recombinant and encapsulated hemoglobin.
    Chang TM
    Vox Sang; 1998; 74 Suppl 2():233-41. PubMed ID: 9704450
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Blood Substitutes and Oxygen Therapeutics: A Review.
    Jahr JS; Guinn NR; Lowery DR; Shore-Lesserson L; Shander A
    Anesth Analg; 2021 Jan; 132(1):119-129. PubMed ID: 30925560
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Liposome-encapsulated hemoglobin: historical development of a blood substitute.
    Goins B; Rudolph AS; Ligler FS
    Biotechnology; 1991; 19():117-25. PubMed ID: 1786468
    [No Abstract]   [Full Text] [Related]  

  • 48. Cerebral oxygen delivery by liposome-encapsulated hemoglobin: a positron-emission tomographic evaluation in a rat model of hemorrhagic shock.
    Awasthi V; Yee SH; Jerabek P; Goins B; Phillips WT
    J Appl Physiol (1985); 2007 Jul; 103(1):28-38. PubMed ID: 17615284
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Liposome encapsulated hemoglobin: long-term storage stability and in vivo characterization.
    Cliff RO; Ligler F; Goins B; Hoffmann PM; Spielberg H; Rudolph AS
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):619-26. PubMed ID: 1391485
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Haemoglobin-based blood substitutes: what's on the horizon?
    Dietz NM; Joyner MJ
    Ann Acad Med Singap; 1994 Nov; 23(6 Suppl):71-6. PubMed ID: 7710240
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Liposome-encapsulated hemoglobin: a synthetic red cell.
    Farmer MC; Johnson SA; Beissinger RL; Gossage JL; Lynn AB; Carter KA
    Adv Exp Med Biol; 1988; 238():161-70. PubMed ID: 3250239
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Encapsulation of hemoglobin in non-phospholipid vesicles.
    Vandegriff KD; Wallach DF; Winslow RM
    Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(3):849-54. PubMed ID: 7994408
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Physical properties and stability mechanisms of poly(ethylene glycol) conjugated liposome encapsulated hemoglobin dispersions.
    Arifin DR; Palmer AF
    Artif Cells Blood Substit Immobil Biotechnol; 2005; 33(2):137-62. PubMed ID: 15960077
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Liposome-encapsulated hemoglobin modulates lipopolysaccharide-induced tumor necrosis factor-alpha production in mice.
    Rudolph AS; Cliff R; Kwasiborski V; Neville L; Abdullah F; Rabinovici R
    Crit Care Med; 1997 Mar; 25(3):460-8. PubMed ID: 9118663
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Rheological properties of hemoglobin vesicles (artificial oxygen carriers) suspended in a series of plasma-substitute solutions.
    Sakai H; Sato A; Takeoka S; Tsuchida E
    Langmuir; 2007 Jul; 23(15):8121-8. PubMed ID: 17567054
    [TBL] [Abstract][Full Text] [Related]  

  • 56. New generation of hemoglobin-based oxygen carriers evaluated for oxygenation of critically ischemic hamster flap tissue.
    Contaldo C; Plock J; Sakai H; Takeoka S; Tsuchida E; Leunig M; Banic A; Erni D
    Crit Care Med; 2005 Apr; 33(4):806-12. PubMed ID: 15818109
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Microvascular responses to hemodilution with Hb vesicles as red blood cell substitutes: influence of O2 affinity.
    Sakai H; Tsai AG; Rohlfs RJ; Hara H; Takeoka S; Tsuchida E; Intaglietta M
    Am J Physiol; 1999 Feb; 276(2):H553-62. PubMed ID: 9950857
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Static structures and dynamics of hemoglobin vesicle (HBV) developed as a transfusion alternative.
    Sato T; Sakai H; Sou K; Medebach M; Glatter O; Tsuchida E
    J Phys Chem B; 2009 Jun; 113(24):8418-28. PubMed ID: 19469497
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Safety Evaluation of Hemoglobin-Albumin Cluster "HemoAct" as a Red Blood Cell Substitute.
    Haruki R; Kimura T; Iwasaki H; Yamada K; Kamiyama I; Kohno M; Taguchi K; Nagao S; Maruyama T; Otagiri M; Komatsu T
    Sci Rep; 2015 Jul; 5():12778. PubMed ID: 26220366
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Blood substitutes. What they are and how they might be used.
    Dong Q; Stowell CP
    Am J Clin Pathol; 2002 Dec; 118 Suppl():S71-80. PubMed ID: 14569814
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.